Skip to main content



Dr. Namratha Kodali is board-certified in medical oncology, hematology, and internal medicine, and practices at our Beaches location. Originally from India, Dr. Kodali earned her Doctor of Medicine from Deccan College of Medical Sciences before moving to America to her fellowship at Penn State University.

Like so many, the physician-owned model drew her to CSNF:

“Being physician owned and operated means that my colleagues and I are dedicated to providing patients with the utmost care and compassion. We’re able to do this by making decisions based solely on the patient’s best interests. The gratitude that we receive is truly unmatched.”

When it comes to her practice, Dr. Kodali wants her patients to know she treats the patient, not just their diagnosis. “I make sure to alleviate not only the pain and suffering, but also the stress and anxiety that is associated with the illness,” she explains. “At CSNF, the comprehensive team allows me to help patients in ways I’ve never been able to before.”

“The patient/physician relationship has always been the most important and rewarding part of my job,” she continues. “I’m humbled by the trust my patients place in me. Although difficult, I get great satisfaction knowing that I’m helping patients and their loved ones get through such a challenging time.”

When not at the office, Dr. Kodali enjoys spending time with her husband and two children. The family of four loves to travel, try new cuisines, and enjoy all of the outdoor activities and year-long sunshine that North Florida has to offer.

Curriculum Vitae


Medical Oncology
Internal Medicine


Penn State University, Hershey Medical Center


UPMC Pinnacle Health System


Deccan College of Medical Sciences
Doctor of Medicine


Diagnosis and management of ovarian vein thrombosis in a healthy individual: a case report and a literature review
A widened pulse pressure: a potential valuable prognostic indicator of mortality in patients with sepsis
Journal of Community Hospital Internal Medicine
Pseudophyperphosphatemia in a patient with incidentally identified progression of smoldering myeloma.
Clinical Chimica Acta